Annual Short Term Debt
$1.78 B
+$109.00 M+6.52%
December 31, 2024
Summary
- As of February 6, 2025, TEVA annual short term debt is $1.78 billion, with the most recent change of +$109.00 million (+6.52%) on December 31, 2024.
- During the last 3 years, TEVA annual short term debt has risen by +$355.00 million (+24.89%).
- TEVA annual short term debt is now -58.39% below its all-time high of $4.28 billion, reached on December 31, 2011.
Performance
TEVA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$1.78 B
-$799.00 M-30.97%
December 31, 2024
Summary
- As of February 6, 2025, TEVA quarterly short term debt is $1.78 billion, with the most recent change of -$799.00 million (-30.97%) on December 31, 2024.
- Over the past year, TEVA quarterly short term debt has dropped by -$1.28 billion (-41.80%).
- TEVA quarterly short term debt is now -59.20% below its all-time high of $4.37 billion, reached on March 31, 2012.
Performance
TEVA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
TEVA Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.5% | -41.8% |
| 3 y3 years | +24.9% | +3.6% |
| 5 y5 years | -24.1% | -44.1% |
TEVA Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.6% | +24.9% | -41.8% | +74.1% |
| 5 y | 5-year | -44.1% | +24.9% | -49.5% | +74.1% |
| alltime | all time | -58.4% | >+9999.0% | -59.2% | >+9999.0% |
Teva Pharmaceutical Industries Limited Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.78 B(+6.5%) | $1.78 B(-31.0%) |
| Sep 2024 | - | $2.58 B(+23.2%) |
| Jun 2024 | - | $2.09 B(-31.6%) |
| Mar 2024 | - | $3.06 B(+83.0%) |
| Dec 2023 | $1.67 B(-20.7%) | $1.67 B(+13.0%) |
| Sep 2023 | - | $1.48 B(-25.3%) |
| Jun 2023 | - | $1.98 B(+93.5%) |
| Mar 2023 | - | $1.02 B(-51.5%) |
| Dec 2022 | $2.11 B(+47.9%) | $2.11 B(-23.8%) |
| Sep 2022 | - | $2.77 B(+61.1%) |
| Jun 2022 | - | $1.72 B(-17.2%) |
| Mar 2022 | - | $2.08 B(+45.7%) |
| Dec 2021 | $1.43 B(-55.3%) | $1.43 B(-47.4%) |
| Sep 2021 | - | $2.71 B(-23.3%) |
| Jun 2021 | - | $3.53 B(+30.9%) |
| Mar 2021 | - | $2.70 B(-15.4%) |
| Dec 2020 | $3.19 B(+35.9%) | $3.19 B(+51.4%) |
| Sep 2020 | - | $2.11 B(+27.7%) |
| Jun 2020 | - | $1.65 B(+1.2%) |
| Mar 2020 | - | $1.63 B(-30.5%) |
| Dec 2019 | $2.35 B(+5.8%) | $2.35 B(-25.1%) |
| Sep 2019 | - | $3.13 B(+13.0%) |
| Jun 2019 | - | $2.77 B(-0.7%) |
| Mar 2019 | - | $2.79 B(+25.9%) |
| Dec 2018 | $2.22 B(-39.2%) | $2.22 B(-17.1%) |
| Sep 2018 | - | $2.67 B(+110.1%) |
| Jun 2018 | - | $1.27 B(-2.3%) |
| Mar 2018 | - | $1.30 B(-64.3%) |
| Dec 2017 | $3.65 B(+11.3%) | $3.65 B(+33.5%) |
| Sep 2017 | - | $2.73 B(+119.2%) |
| Jun 2017 | - | $1.25 B(-35.8%) |
| Mar 2017 | - | $1.94 B(-40.7%) |
| Dec 2016 | $3.28 B(+106.7%) | $3.28 B(-10.9%) |
| Sep 2016 | - | $3.68 B(+27.6%) |
| Jun 2016 | - | $2.88 B(+82.3%) |
| Mar 2016 | - | $1.58 B(-0.3%) |
| Dec 2015 | $1.58 B(-10.0%) | $1.58 B(-26.2%) |
| Sep 2015 | - | $2.15 B(-28.9%) |
| Jun 2015 | - | $3.02 B(+85.9%) |
| Mar 2015 | - | $1.63 B(-7.7%) |
| Dec 2014 | $1.76 B(-2.4%) | $1.76 B(-3.9%) |
| Sep 2014 | - | $1.83 B(-10.5%) |
| Jun 2014 | - | $2.05 B(+32.0%) |
| Mar 2014 | - | $1.55 B(-14.0%) |
| Dec 2013 | $1.80 B(-40.0%) | $1.80 B(-28.9%) |
| Sep 2013 | - | $2.54 B(+0.1%) |
| Jun 2013 | - | $2.53 B(-6.8%) |
| Mar 2013 | - | $2.72 B(-9.5%) |
| Dec 2012 | $3.01 B(-29.8%) | $3.01 B(+172.8%) |
| Sep 2012 | - | $1.10 B(-22.4%) |
| Jun 2012 | - | $1.42 B(-67.5%) |
| Mar 2012 | - | $4.37 B(+2.0%) |
| Dec 2011 | $4.28 B(+54.5%) | $4.28 B(+12.2%) |
| Sep 2011 | - | $3.81 B(+55.2%) |
| Jun 2011 | - | $2.46 B(+31.0%) |
| Mar 2011 | - | $1.88 B(-32.3%) |
| Dec 2010 | $2.77 B | $2.77 B(+15.1%) |
| Sep 2010 | - | $2.41 B(+23.7%) |
| Jun 2010 | - | $1.95 B(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $1.97 B(+51.7%) |
| Dec 2009 | $1.30 B(-55.2%) | $1.30 B(-11.9%) |
| Sep 2009 | - | $1.48 B(-27.2%) |
| Jun 2009 | - | $2.03 B(-39.6%) |
| Mar 2009 | - | $3.36 B(+15.5%) |
| Dec 2008 | $2.91 B(+57.8%) | $2.91 B(+290.6%) |
| Sep 2008 | - | $744.00 M(-47.9%) |
| Jun 2008 | - | $1.43 B(-29.7%) |
| Mar 2008 | - | $2.03 B(+10.4%) |
| Dec 2007 | $1.84 B(+148.1%) | $1.84 B(-5.7%) |
| Sep 2007 | - | $1.95 B(+28.1%) |
| Jun 2007 | - | $1.52 B(+0.2%) |
| Mar 2007 | - | $1.52 B(+105.0%) |
| Dec 2006 | $742.00 M(+97.3%) | $742.00 M(+0.7%) |
| Sep 2006 | - | $737.20 M(-30.2%) |
| Jun 2006 | - | $1.06 B(-0.6%) |
| Mar 2006 | - | $1.06 B(+182.4%) |
| Dec 2005 | $376.00 M(-32.9%) | $376.00 M(-3.6%) |
| Sep 2005 | - | $390.00 M(-7.0%) |
| Jun 2005 | - | $419.50 M(-16.5%) |
| Mar 2005 | - | $502.60 M(-10.3%) |
| Dec 2004 | $560.00 M(-13.1%) | $560.00 M(+25.8%) |
| Sep 2004 | - | $445.20 M(-35.9%) |
| Jun 2004 | - | $694.30 M(-2.0%) |
| Mar 2004 | - | $708.30 M(+10.0%) |
| Dec 2003 | $644.20 M(-12.8%) | $644.20 M(-44.4%) |
| Sep 2003 | - | $1.16 B(+46.7%) |
| Jun 2003 | - | $789.90 M(+2.5%) |
| Mar 2003 | - | $770.50 M(+4.3%) |
| Dec 2002 | $738.50 M(+257.6%) | $738.50 M(+349.5%) |
| Sep 2002 | - | $164.30 M(+8.3%) |
| Jun 2002 | - | $151.70 M(-2.3%) |
| Mar 2002 | - | $155.30 M(-24.8%) |
| Dec 2001 | $206.52 M(-39.5%) | $206.52 M(-0.3%) |
| Sep 2001 | - | $207.10 M(+7.3%) |
| Jun 2001 | - | $192.95 M(-12.0%) |
| Mar 2001 | - | $219.30 M(-35.8%) |
| Dec 2000 | $341.52 M(+23.6%) | $341.52 M(-33.6%) |
| Jun 2000 | - | $514.06 M(+77.8%) |
| Mar 2000 | - | $289.13 M(+4.7%) |
| Dec 1999 | $276.26 M(-14.9%) | $276.26 M(-36.7%) |
| Sep 1999 | - | $436.60 M(+52.6%) |
| Jun 1999 | - | $286.10 M(-10.3%) |
| Mar 1999 | - | $319.10 M(-1.7%) |
| Dec 1998 | $324.50 M(+35.3%) | $324.50 M(-2.3%) |
| Sep 1998 | - | $332.30 M(+24.9%) |
| Jun 1998 | - | $266.10 M(+21.3%) |
| Mar 1998 | - | $219.30 M(-8.5%) |
| Dec 1997 | $239.80 M(-29.7%) | $239.80 M(-29.7%) |
| Dec 1996 | $341.20 M(+33.7%) | $341.20 M(+33.7%) |
| Dec 1995 | $255.20 M(+84.5%) | $255.20 M(+84.5%) |
| Dec 1994 | $138.30 M(+26.5%) | $138.30 M(+26.5%) |
| Dec 1993 | $109.30 M(+13.0%) | $109.30 M(+13.0%) |
| Dec 1992 | $96.70 M(+69.4%) | $96.70 M(+69.4%) |
| Dec 1991 | $57.10 M(+3.1%) | $57.10 M(+3.1%) |
| Dec 1990 | $55.40 M(+122.5%) | $55.40 M(+122.5%) |
| Dec 1989 | $24.90 M(-27.6%) | $24.90 M(-27.6%) |
| Dec 1988 | $34.40 M(+134.0%) | $34.40 M(+134.0%) |
| Mar 1987 | $14.70 M(0.0%) | $14.70 M(0.0%) |
| Mar 1986 | $14.70 M | $14.70 M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual short term debt?
- What is the all time high annual short term debt for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual short term debt year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly short term debt?
- What is the all time high quarterly short term debt for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly short term debt year-on-year change?
What is Teva Pharmaceutical Industries Limited annual short term debt?
The current annual short term debt of TEVA is $1.78 B
What is the all time high annual short term debt for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual short term debt is $4.28 B
What is Teva Pharmaceutical Industries Limited annual short term debt year-on-year change?
Over the past year, TEVA annual short term debt has changed by +$109.00 M (+6.52%)
What is Teva Pharmaceutical Industries Limited quarterly short term debt?
The current quarterly short term debt of TEVA is $1.78 B
What is the all time high quarterly short term debt for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly short term debt is $4.37 B
What is Teva Pharmaceutical Industries Limited quarterly short term debt year-on-year change?
Over the past year, TEVA quarterly short term debt has changed by -$1.28 B (-41.80%)